PWE Stock Chart & Stats
€0.13
<€0.01(0.93%)
At close: 4:00 PM EST
€0.13
<€0.01(0.93%)
Day’s Range― - ―
52-Week Range€0.08 - €0.17
Previous CloseN/A
Volume0.00
Average Volume (3M)5.00
Market Cap
€142.84M
Enterprise Value€506.82
Total Cash (Recent Filing)€1.83B
Total Debt (Recent Filing)€21.03M
Price to Earnings (P/E)26.6
Beta0.17
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding1,433,241,100
10 Day Avg. Volume0
30 Day Avg. Volume5
Financial Highlights & Ratios
PEG Ratio-0.51
Price to Book (P/B)0.44
Price to Sales (P/S)2.13
P/FCF Ratio12.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Low LeverageThe extremely low debt burden gives PW Medtech substantial financial resilience and flexibility. Limited leverage reduces interest and refinancing pressure, allowing the company to withstand operating volatility and retain capacity to fund investment or return capital over the next several quarters.
Positive Cash GenerationPositive operating and free cash flow show that the business continues to generate cash internally despite weaker recent performance. This supports ongoing operations, investment and capital allocation without relying heavily on additional borrowing, reinforcing the company’s conservative financial profile.
Established Profitability And Gross MarginsThe multi-year record of growth and solid gross margins indicates an established business with meaningful operating economics. Although FY2025 weakened, this historical profitability provides a foundation for recovery if revenue trends stabilize and margins regain part of their previous strength.
Bears Say
Recent Revenue DeclineThe FY2025 revenue contraction signals weaker demand or reduced business momentum compared with the prior year. If the decline persists, it can limit operating leverage, reduce resources available for reinvestment, and make a return to the company’s earlier growth trajectory more difficult.
Material Margin CompressionThe sharp decline in both net and EBITDA margins reduces earnings quality and demonstrates that profitability is not currently as durable as in FY2024. Continued compression would weaken internal cash generation, lower returns on the asset base, and constrain funding for future growth.
Volatile Free Cash FlowAlthough cash flow remains positive, repeated year-over-year weakening shows that conversion into discretionary cash has been inconsistent. This volatility can make investment planning and capital allocation less predictable, particularly while revenue and margins are also under pressure.
PW Medtech Group Ltd. News
PWE FAQ
What was PW Medtech Group Ltd.’s price range in the past 12 months?
PW Medtech Group Ltd. lowest stock price was €0.08 and its highest was €0.17 in the past 12 months.
What is PW Medtech Group Ltd.’s market cap?
PW Medtech Group Ltd.’s market cap is €142.84M.
When is PW Medtech Group Ltd.’s upcoming earnings report date?
PW Medtech Group Ltd.’s upcoming earnings report date is Apr 01, 2027 which is in 187 days.
How were PW Medtech Group Ltd.’s earnings last quarter?
PW Medtech Group Ltd. released its earnings results on Aug 28, 2026. The company reported €0.001 earnings per share for the quarter.
Is PW Medtech Group Ltd. overvalued?
According to Wall Street analysts PW Medtech Group Ltd.’s price is currently Overvalued.
Does PW Medtech Group Ltd. pay dividends?
PW Medtech Group Ltd. does not currently pay dividends.
What is PW Medtech Group Ltd.’s EPS estimate?
PW Medtech Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PW Medtech Group Ltd. have?
PW Medtech Group Ltd. has 1,433,241,100 shares outstanding.
What happened to PW Medtech Group Ltd.’s price movement after its last earnings report?
PW Medtech Group Ltd. reported an EPS of €0.001 in its last earnings report. Following the earnings report the stock price went up 1.205%.
Which hedge fund is a major shareholder of PW Medtech Group Ltd.?
Currently, no hedge funds are holding shares in DE:PWE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PW Medtech Group Ltd.
Operating within the People's Republic of China, PW Medtech Group Limited is an investment holding company primarily engaged in the medical device industry. The company specializes in the manufacturing and distribution of a diverse portfolio of medical consumables, including various types of infusion sets such as non-PVC, precision filter, and light-resistant models, alongside intravenous cannula products and insulin needles and pens. Beyond its core medical device activities, the group also provides property management services. Established in 1997, the company, previously known as Pyholding Limited, maintains its corporate headquarters in Beijing, China.
Technical Analysis
Shandong Weigao Group Medical Polymer Co
―
Modern Dental Group Limited
―
Shanghai Kindly Medical Instruments Co., Ltd. Class H
―
Angelalign Technology Inc.
―
OrbusNeich Medical Group Holdings Limited
―